Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Editor's note channel feed
Join us at 12 p.m. ET: How pharma is reacting to ‘Liberation Day’
4 weeks ago
Pharma
Endpoints wins SABEW 'Best in Business' award for Health Tech coverage and newsletter
2 months ago
Health Tech
Post-Hoc: Pharma CEOs' alternative reality with Trump
3 months ago
Pharma
We’re about to find out which RFK Jr. will show up at HHS
3 months ago
The new China dynamic, Trump 2.0, markets and more: See you tomorrow at JPM!
4 months ago
Post-Hoc: Biosecure is dead. Long live Biosecure?
5 months ago
China
Manufacturing
Post-Hoc: Trying to make sense of a killing
5 months ago
Health Tech
Post-Hoc: RFK vs. Vivek, and the future of US drug policy
6 months ago
FDA+
Pfizer’s make-or-break quarter
6 months ago
Pharma
Post-Hoc: Novo’s obesity enemies
7 months ago
Pharma
Manufacturing
Post-Hoc: What does an activist want with Pfizer?
7 months ago
Post-Hoc: Big promises built Moderna. They might also be its undoing
8 months ago
The Endpoints 11 event is coming: Meet biotech’s hottest new startups
8 months ago
See you at BIO: China tensions, fixing gene therapy’s business model, and the stop-start market recovery
Last year
Antitrust, AI and Alzheimer’s: Join us in New York next week
Last year
From the editor: Our final edition of Endpoints MarketingRx
Last year
Marketing
Introducing Post-Hoc: Our latest newsletter with analysis and insights
Last year
From the newsroom: Endpoints wins a SABEW award for general excellence
Last year
#JPM24 reflections: No politics, no Miami and where the money is in biotech right now
Last year
What we’re doing differently at JP Morgan this year
Last year
Did I ever tell you the one about the drunken biotech awards program I hosted at a Chicago bar?
Last year
Bioregnum
Why Endpoints is bringing a new focus to our manufacturing coverage
Last year
Manufacturing
Expanding the Endpoints newsroom overseas, a special projects hire and our new lead for events
Last year
How you access Endpoints News is changing
Last year
1
2
3
Next page
Last page